Article
Modeling SMAD2 Mutations in Induced Pluripotent Stem Cells Provides Insights Into Cardiovascular Disease Pathogenesis.
Journal of the American Heart Association - 4 Mar 2025
Ward Tarsha, Morton Sarah U, Venturini Gabriela, Tai Warren, Jang Min Young, Gorham Joshua, Delaughter Dan, Wasson Lauren K, Khazal Zahra, Homsy Jason, Gelb Bruce D, Chung Wendy K, Bruneau Benoit G, Brueckner Martina, Tristani-Firouzi Martin, DePalma Steven R, Seidman Christine, Seidman J G
Abstract excerpt
BACKGROUND: SMAD2 is a coregulator that binds a variety of transcription factors in human development. Heterozygous SMAD2 loss-of-function and missense variants are identified in patients with congenital heart disease (CHD) or arterial aneurysms. Mechanisms that cause distinct cardiovascular phenotypes remain unknown. We aimed to define transcriptional and epigenetic effects of SMAD2 variants and their role in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
